NCT05051124Completed
Peers and Technology for Adherence, Access, Accountability, and Analytics
PT4A (Peers and Technology for Adherence, Access, Accountability, and Analytics) - A Qualitative Study
Source: ClinicalTrials.gov · Last updated 19 Mar 2025
Brief summary (registry, in English)
The overall objective of this project is to utilize the PRECEDE-PROCEED framework to conduct transdisciplinary, translational implementation research focused on improving medication adherence for hypertension control. The central hypothesis is that peer delivery of medications integrated with HIT (PT4A) will be effective in improving hypertension medication adherence, contributing to improved blood pressure among patients with uncontrolled hypertension in western Kenya. This study record will focus on Sub-Aim 2.2: a pilot of the intervention and a survey questionnaire with patients, peers, and clinical staff to evaluate feasibility. The investigators will evaluate impact on systolic blood pressure, medication adherence, and fidelity of implementation. The investigators will also create a retrospective comparator (control) group of CDM patients, through querying AMRS, matched by sex, age, location and initial blood pressure level. The investigators will then use their recorded blood pressure over a comparable period of up to 1 year and to allow for comparison to the blood pressure changes observed in the patients enrolled in the PT4A program to help understand the magnitude and variance of the intervention effects.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 10 Sept 2021
- Start date
- 19 Apr 2022
- Primary completion date
- 25 Jan 2024
- Lead sponsor
- NYU Langone Health
- Diseases
- High blood pressure
- NCT number
- NCT05051124
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 19 Apr 2022 to the primary completion date, 25 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute illness requiring immediate medical attention
- Terminal illness
Other
- Inability to provide informed consent
Who the study is looking for
- Adult patients ≥ 18 years old
- Enrolled in the AMPATH CDM PRogram
- Have uncontrolled hypertension (defined as systolic blood pressures ≥ 140 or diastolic blood pressure ≥ 90)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.